Sasanlimab Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: PF-06801591

Filter by location:

Birmingham, Alabama1 trial

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

University of Alabama at Birmingham

Phase 1

Bethesda, Maryland1 trial

Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)

National Institutes of Health Clinical Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.